Evidence map›Paper›PMID 41217173›Full record

ArticleJournal of virology2025

Ceramide synthase 4 interferes with replication of influenza virus but is downregulated by infection.

Kwang Il Jung, Chuan Xia, Savannah McKenna, Ying He, Vijayamahantesh Vijayamahantesh, Jennifer J Wolf, Bumsuk Hahm

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Measles virus reprograms CD4Frontiers in cell and developmental biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kwang Il JungDepartment of Surgery, University of Missouri, Columbia, Missouri, USA.ORCID 0009-0001-4295-1539
Chuan XiaDepartment of Surgery, University of Missouri, Columbia, Missouri, USA.
Savannah McKennaDepartment of Surgery, University of Missouri, Columbia, Missouri, USA.
Ying HeDepartment of Surgery, University of Missouri, Columbia, Missouri, USA.
Vijayamahantesh VijayamahanteshDepartment of Surgery, University of Missouri, Columbia, Missouri, USA.
Jennifer J WolfDepartment of Surgery, University of Missouri, Columbia, Missouri, USA.
Bumsuk HahmDepartment of Surgery, University of Missouri, Columbia, Missouri, USA.ORCID 0000-0002-0083-6129

Funding

Interplay between influenza virus and S1P-metabolizing enzymesR01AI162631 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI HAHM, BUMSUK · 2021 to 2025
$2.2M
Regulation of host immunity to impact virus persistenceR01AI153076 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI HAHM, BUMSUK · 2021 to 2025
$2.1M
NIAID NIH HHS R01 AI153076NIAID NIH HHS R01 AI162631
6 · The paper itself

Abstract

Influenza continues to pose a serious threat to humans. Influenza-host interaction is incompletely understood, requiring identification of host factors that regulate viral pathogenicity. Ceramide synthases (CerSs) are responsible for producing and controlling ceramide levels within cells. Ceramides are structural and signaling sphingolipid components that mediate various biological functions and affect the infectivity of multiple viruses. However, the role of CerSs during virus infections remains unclear. In this study, we investigated the possible function of CerSs in host defense against influenza virus infection. Cells stably expressing CerS4 poorly supported influenza virus replication, whereas CerS1 did not affect replication. Transient overexpression of CerS4 also impaired the efficient production of viral proteins as well as infectious progeny viruses. In support of these results, knockdown of endogenous CerS4 in cells enhanced virus replication. Intriguingly, CerS4 impeded virus-induced activation of cellular c-Jun N-terminal kinase (JNK), which interfered with influenza viral replication. On the other hand, influenza virus infection was shown to induce CerS4 ubiquitination and downregulation, which could limit the antiviral activity of CerS4. Collectively, these findings reveal a new function of CerS4 that restricts influenza virus infection and provides valuable insights into influenza-host defense interactions.IMPORTANCESeasonal influenza causes serious public health problems in the world with substantial annual morbidity and mortality. Further, there have been persistent concerns about potential development of an influenza pandemic. Current antiviral drugs are limited in their efficacy, especially due to the rapid emergence of drug-resistant variants. Host protein-directed therapy is an alternative or complementary approach to broadly controlling influenza virus infections but requires a deeper understanding of influenza-host interplay. Host ceramide synthase 4 regulates the level of ceramides that possess both structural and signaling mediator functions. Our study reveals that ceramide synthase 4 displays an antiviral activity against influenza virus infection by regulating JNK activation. However, influenza virus triggers degradation of ceramide synthase 4, which could favor virus replication. The findings advance our knowledge about the ceramide network interaction with influenza and provide a framework for developing a host-targeted therapy to cure influenza.

Indexed as

Influenza, HumanOxidoreductasesSphingosine N-AcyltransferaseVirus ReplicationA549 CellsAnimalsCell LineCeramidesDogsDown-RegulationHEK293 CellsHost-Pathogen InteractionsHumansJNK Mitogen-Activated Protein KinasesMadin Darby Canine Kidney CellsUbiquitinationCeramidesdihydroceramide desaturaseJNK Mitogen-Activated Protein KinasesOxidoreductasesSphingosine N-Acyltransferaseceramide synthase 4influenza-host interactioninfluenza virusJNK regulation

Identifiers

PMID41217173
PMCPMC12724325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.